Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2018

Mar 1, 2018

34129_dirs_2018-03-01_7898fb36-6c05-4b18-a076-b3b5acd5249e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-02-28

Reporting Person: Cilinski Lynn (VP, Controller and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-28 Common Stock M 7989 $0.94 Acquired 9912 Direct
2018-02-28 Common Stock M 7989 $0.94 Acquired 17901 Direct
2018-02-28 Common Stock M 7989 $1.51 Acquired 25890 Direct
2018-02-28 Common Stock S 23967 $25.0109 Disposed 1923 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-28 Employee stock option (right to buy) $0.94 M 7989 Disposed 2021-01-08 Common Stock (7989.0) Direct
2018-02-28 Employee stock option (right to buy) $0.94 M 7989 Disposed 2022-03-13 Common Stock (7989.0) Direct
2018-02-28 Employee stock option (right to buy) $1.51 M 7989 Disposed 2023-01-05 Common Stock (7989.0) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017.

F2: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.